De Novo Prostate Cancer
Oncology
Prevalence
256.0 / 100K
Incidence
111.0 / 100K/yr
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target De Novo Prostate Cancer?
There are 1 clinical trial targeting De Novo Prostate Cancer tracked by BioSniper.
What is the prevalence of De Novo Prostate Cancer?
The estimated prevalence of De Novo Prostate Cancer is approximately 256.0 per 100,000 population.
Deep-dive into De Novo Prostate Cancer
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis